Rabies vaccine(MRC-5-cell) (Anhui Zhifei Longcom Biopharmaceutical)

狂犬病疫苗（MRC-5细胞）（安徽智飞龙科马）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRabies vaccine(MRC-5-cell) (Anhui Zhifei Longcom Biopharmaceutical)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsRabies
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsDrug-Related Side Effects and Adverse ReactionsRabies
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A